Navina vs Reveleer (2026)

AI Health Index verifiedSeptember 22, 2026
Verdict

The prospective against the retrospective answer to the same contract, and most organizations under risk need both. Navina works inside the visit, surfacing suspected conditions with evidence attached so the clinician documents while the patient is in front of them. Reveleer works after it, retrieving records, parsing charts and populating risk adjustment and quality submissions, which is the machinery that closes a year once the visits are gone. The difference in cost and posture is real: prospective work improves the encounter and the documentation together, retrospective work recovers what the encounter missed and looks more like an audit than like care. Both vendors have the same unanswered question, which is what proportion of the conditions they surface a clinician confirms, and whether either flags codes that should come off as readily as codes that should go on.

The case for Navina
  • Prospective rather than retrospective. Conditions are surfaced to the clinician during the encounter with evidence attached, so documentation happens while the patient is present rather than through a chart chase afterwards.
  • Proprietary language models classify documents and extract structure from free text across the record, exchanges and claims, which is a broader input set than record retrieval alone.
  • Named and typed certifications, ISO 27001 and SOC 2 Type II with the type stated, plus native bidirectional integration in workflow.
The case for Reveleer
  • Retrospective completeness is a different job and this platform is built for it, automating record retrieval, parsing charts and populating both risk adjustment and quality submissions.
  • Retrieval is the hard part of retrospective work and it owns that step rather than assuming the charts arrive, which is what determines whether a submission is complete.
  • Quality reporting sits alongside risk adjustment in the same platform, so one workflow serves two regulatory obligations rather than two vendors serving one each.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Navina and Reveleer are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact Navina Reveleer
Primary category Clinical Decision Support Value Based Care Intelligence
Founded 2018 2009
Headquarters New York, New York, United States Glendale, California, United States
Website navina.ai reveleer.com
Attribute Matrix

Side by Side

Select any grade to read the note behind it.

Axis
N
Navina
R
Reveleer
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Citable Summaries

Each vendor in one paragraph

Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.

Navina

Clinician copilot that ingests data across the EHR, health information exchanges, insurance claims, and care gap files, then uses proprietary language models to classify documents and extract structure from free text, producing a consolidated Patient Portrait at the point of care. Surfaces suspected chronic conditions never explicitly documented, infers hierarchical condition categories for risk adjustment, and supports HEDIS care gap closure, with every insight linked back to the underlying clinical evidence.

Source: AI Health Index, September 2026

Reveleer

Reveleer is a Glendale, California company founded in 2009 as a medical record retrieval business and since rebuilt as a value based care platform for health plans and risk bearing providers across Medicare Advantage, ACA Marketplace and Medicaid.

Source: AI Health Index, September 2026

FAQ

Questions buyers ask

How do Navina and Reveleer work with the EHR?

For Navina, the home page shows athenahealth, Epic and Veradigm as EHR integration partners. Navina's February 2024 announcement describes the platform live inside the Epic environment of NOMS Healthcare, with diagnosis recommendations presented in Epic's Best Practice Advisory alongside a link to the source evidence, and Navina's own listing on the Avia marketplace names Epic, eClinicalWorks, athenahealth and Allscripts.

With Reveleer, the EVE page says prospective insights are delivered directly into point of care record workflows, and the company's clinical data repository page says it integrates with record systems, health information exchanges, retrieval vendors and internal data warehouses, with charts moved by bulk upload, SFTP or API. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 22, 2026. No vendor pays for placement.

How are Navina and Reveleer priced and sold?

In Navina's case, the benefit side is better evidenced: an independent study by the American Academy of Family Physicians reported a 30 percent reduction in chart review burden and a 23 percent reduction in burnout, and the product was named 2025 Best in KLAS for clinician digital workflow.

For Reveleer, one possibility is specific to risk adjustment, where a vendor is sometimes paid a share of the incremental payment its work produces. If any part of an arrangement is contingent on conditions found, the fee runs the same direction as the coding, and the party absorbing an over captured condition is the federal program rather than the plan. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 22, 2026. No vendor pays for placement.

How do Navina and Reveleer handle patient data?

With Navina, data processed on behalf of a customer is retained for as long as the service runs and a reasonable time after; data is stored on AWS in North Virginia; and information the company anonymizes or de identifies may be used and disclosed to third parties without restriction, including to improve its services. The core technology page adds that Navina is built with strict data governance, HIPAA compliance and encryption.

In Reveleer's case, the company has described processing over 1.2 billion pages of clinical data a year for more than 55 health plans. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 22, 2026. No vendor pays for placement.

Which settings and specialties do Navina and Reveleer cover?

For Navina, the value based tie is the product itself: HCC risk adjustment and RAF accuracy, HEDIS quality measures and care gap closure, and analytics tracking value based performance, with the FAQ covering risk adjustment audits for Medicare Advantage plans. The company has extended into ambient transcription combined with historical data, widening from a pre visit tool toward the full encounter.

With Reveleer, the home page lists member management, prospective risk adjustment, quality improvement with care gap management, HEDIS audit and provider directory validation, and retrospective risk adjustment with RADV audit support, sold to payers and to providers and ACOs, across Medicare Advantage, ACA Marketplace and Medicaid programs. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 22, 2026. No vendor pays for placement.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Autonomous Medical Coding page.

Disclosure

Prospective and retrospective risk adjustment are complementary and most risk bearing organizations run both, so treat this as a sequencing question rather than a choice. The governance issue is the same on both sides and neither addresses it: a platform that surfaces more diagnoses raises risk adjusted revenue whether or not the patient is sicker, and neither vendor publishes a confirmation rate, an add to delete ratio, or evidence that it flags codes lacking documentation for removal as readily as it suggests additions. Ask both for the two way number. Neither publishes pricing.